CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ilsung IS Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ilsung IS Co Ltd
9, Wonhyo-ro 84-gil, Yongsan-gu
Phone: +82 232718800p:+82 232718800 SEOUL, 04315  South Korea Ticker: 003120003120
Business Summary
BRIEF: For the three months ended 31 March 2026, Ilsung IS Co Ltd revenues increased 1% to W16.71B. Net income increased 3% to W1.58B. Revenues reflect Injections segment increase of 22% to W2.56B, Refinement segment increase of 4% to W11.14B, Capsule segment increase of 27% to W983M. Net income benefited from South Korea segment loss decrease of 51% to W495.8M. Basic Earnings per Share excluding Extraordinary Items decreased from W225.76 to W220.23.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director Dae SikUhm 64 4/28/2025 1/1/2024
Co-Chief Executive Officer, Director Jong HoYoon 42 4/28/2025 1/1/2023
Co-Chief Executive Officer, Director Seok GeunYoon 69 4/28/2025 3/11/2005
10 additional Officers and Directors records available in full report.

Business Names
Business Name
003120
CISC0 CORPERATION
Ilsung Pharmaceutical Co., Ltd

General Information
Number of Employees: 191 (As of 3/31/2026)
Outstanding Shares: 7,162,047 (As of 3/31/2026)
Shareholders: 3,360
Stock Exchange: KRX
Fax Number: +82 27187239


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, July 1, 2026